AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced it will report unaudited consolidated financial results for the quarter ended September 30, 2008 after the U.S. financial markets close on Monday, November 3, 2008. The announcement will be followed by a conference call at 4:30 p.m. ET during which management will discuss the Company’s financial results, business highlights and its development programs.
To access the conference call via telephone, please dial (877) 412-6083 from the United States or (706) 902-1303 for international access. A telephone replay will be available from approximately 5:30 p.m. ET on November 3, 2008 through midnight November 6, 2008. To access a replay of the conference call, dial (800) 642-1687 from the United States or (706) 645-9291 for international access. The passcode for the live call and replay is 70792779.
An audio webcast of the call will be available through the Investors section of the Company’s website at www.amagpharma.com. The webcast replay will be available from approximately 7:30 p.m. ET on November 3, 2008 through midnight December 3, 2008.
About AMAG Pharmaceuticals, Inc.
AMAG Pharmaceuticals, Inc. is a biopharmaceutical company that utilizes its proprietary technology for the development and commercialization of therapeutic iron compounds to treat anemia and novel imaging agents to aid in the diagnosis of cancer and cardiovascular disease.
Contacts:
Carol Miceli, 617-498-3361
cmiceli@amagpharma.com